PFE news and market impact
Real-time Pfizer Inc. news affecting stock and options prices
Latest PFE news
FDA Commissioner Marty Makary resigned following mounting backlash from pharmaceutical companies, physicians, and patient groups over regulatory decisions and faster vape approvals.
FDA Commissioner Marty Makary resigned following mounting backlash from pharmaceutical companies, physicians, and patient groups over regulatory decisions and faster vape approvals. Acting Commissioner Kyle Diamantas will temporarily take over the agency. The resignation ends a tenure marked by internal dysfunction and leadership turmoil.
Headline ingested without LLM analysis.
Headline ingested without LLM analysis
The Trump White House claims negotiated agreements with drugmakers could save the U.S. economy $529 billion over 10 years through cost reductions.
The Trump White House claims negotiated agreements with drugmakers could save the U.S. economy $529 billion over 10 years through cost reductions. The deals represent a policy shift toward pharmaceutical price negotiation and potential regulatory relief.
Jim Cramer highlighted Amazon's aggressive $200 billion capital spending strategy and upcoming profitability timeline (2027-2028) on CNBC's Morning Meeting.
Jim Cramer highlighted Amazon's aggressive $200 billion capital spending strategy and upcoming profitability timeline (2027-2028) on CNBC's Morning Meeting. He characterized Amazon as a 'dormant' tech giant poised for sustained outperformance, noting the stock hit an all-time high following the launch of Amazon Supply Chain Services.
The FDA blocked publication of multiple peer-reviewed studies finding Covid and shingles vaccines safe, with HHS citing overly broad conclusions unsupported by underlying data.
The FDA blocked publication of multiple peer-reviewed studies finding Covid and shingles vaccines safe, with HHS citing overly broad conclusions unsupported by underlying data. This represents a significant shift in vaccine oversight under the Trump administration and HHS Secretary Robert F. Kennedy Jr., a known vaccine skeptic.
The Trump Administration announced a Most-Favored-Nation (MFN) drug pricing policy framework, having secured voluntary pricing agreements with 17 major pharmaceutical manufacturers.
The Trump Administration announced a Most-Favored-Nation (MFN) drug pricing policy framework, having secured voluntary pricing agreements with 17 major pharmaceutical manufacturers. The policy targets price alignment with other high-income countries and is projected to generate $529 billion in domestic savings over 10 years, with plans to codify agreements into law.
Headline ingested without LLM analysis.
Headline ingested without LLM analysis
Headline ingested without LLM analysis.
Headline ingested without LLM analysis
Headline ingested without LLM analysis.
Headline ingested without LLM analysis
Headline ingested without LLM analysis.
Headline ingested without LLM analysis
How news affects PFE
Pfizer Inc. (PFE) is sensitive to: drug approvals, COVID variants, earnings, pipeline data.Global pharma — COVID vaccines, oncology, rare disease.
Related tickers
Get PFE alerts before the market moves
AI-powered news filtering. Only what matters to your positions.
Start free trialFrequently asked questions
What is moving PFE today?
FDA Commissioner Marty Makary resigned following mounting backlash from pharmaceutical companies, physicians, and patient groups over regulatory decisions and faster vape approvals.
How do I get PFE news alerts?
Sign up for Tradar and add PFE to your watchlist. You'll get push notifications for high-impact news within seconds.